Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Trial of Pazopanib in Patients With Metastatic Alveolar Soft Part Sarcoma

NCT02113826 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT02113826
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02113826 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Trial of Pazopanib in Patients With Metastatic Alveolar Soft Part Sarcoma
Lead sponsor
Seoul National University Hospital
Phase
Phase 2
Overall status
Terminated
Start date
April 30, 2014
Completion date
November 30, 2017
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic alveolar soft part sarcoma